We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

First Endocervical Tissue Sampler for Cervical Cancer Diagnosis Captures Comprehensive 360-Degree Sample

By HospiMedica International staff writers
Posted on 04 May 2023
Print article
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)

There is a pressing need for advancements in the current standard of care for diagnosing the presence of cancerous cells in a woman's cervix. When a woman's pap smear yields abnormal results, she usually undergoes a colposcopy, which often involves endocervical curettage or obtaining a tissue sample from the highly sensitive cervical canal. The available tools for collecting this tissue are limited and can cause pain, bleeding, and severe discomfort, as well as produce inadequate or contaminated samples. If sample contamination occurs, additional tests and office visits would be needed to acquire more samples. Now, the first-ever endocervical tissue sampler (curette) designed to collect and secure a comprehensive sample, maximizing quality and quantity, brings much-needed advanced technologies to women.

Femasys Inc.’s (Suwanee, GA, USA) FemCerv, an FDA-cleared endocervical sampler, is the first of its kind, designed to capture a complete and uncontaminated sample through a relatively pain-free procedure. FemCerv features an expandable collection chamber that is exposed during sampling and closed during removal to contain cervical cells and tissue. It can be used alongside colposcopy and aims to capture and preserve a comprehensive 360-degree tissue sample in a relatively pain-free office visit. FemCerv has now also received approval from Health Canada, the Public Health Agency of Canada.

“We are delighted to gain another product approval in Canada, with FemCerv now available to women throughout all of North America as a more advanced alternative for tissue sampling to detect cervical cancer,” said Kathy Lee-Sepsick, Femasys’ founder, president and, chief executive officer.

Related Links:
Femasys Inc. 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Hospital Bed
Alphalite
New
3T MRI Scanner
MAGNETOM Cima.X

Print article
Radcal

Channels

Critical Care

view channel
mage: The electroceutical epidermal patch is designed to inhibit bacterial growth (Photo courtesy of Saehyun Kim/University of Chicago)

Cutting-Edge Bioelectronic Device Offers Drug-Free Approach to Managing Bacterial Infections

Antibiotic-resistant infections pose an increasing threat to patient safety and healthcare systems worldwide. Recent estimates indicate that drug-resistant infections may rise by 70% by 2050, highlighting... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more